XML 29 R17.htm IDEA: XBRL DOCUMENT v3.20.4
Stockholders' Equity
3 Months Ended
Dec. 31, 2020
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
Note 9—Stockholders’ Equity
As-converted class A common stock. The number of shares of each series and class, and the number of shares of class A common stock on an as-converted basis were as follows:
December 31, 2020September 30, 2020
Shares
Outstanding
Conversion Rate Into 
Class A
Common Stock
As-converted Class A
Common
Stock(1)
Shares
Outstanding
Conversion Rate Into
Class A
Common Stock
As-converted Class A
Common
Stock(1)
(in millions, except conversion rates)
Series A preferred stock 
(2)
100.0000 15 — 
(2)
100.0000 35 
UK&I preferred stock2 6.3680 16 6.3870 16 
Europe preferred stock3 6.8530 22 6.8610 22 
Class A common stock(3)
1,696 1,696 1,683 — 1,683 
Class B common stock245 1.6228 
(4)
398 245 1.6228 
(4)
398 
Class C common stock11 4.0000 43 11 4.0000 43 
Total2,190 2,197 
(1)Figures in the table may not recalculate exactly due to rounding. As-converted class A common stock is calculated based on unrounded numbers.
(2)The number of shares outstanding was less than one million.
(3)Class A common stock shares outstanding reflect repurchases that settled on or before December 31, 2020 and September 30, 2020.
(4)The class B to class A common stock conversion rate is presented on a rounded basis. Conversion calculations for dividend payments are based on a conversion rate rounded to the tenth decimal.
Reduction in as-converted shares. Under the terms of the Europe retrospective responsibility plan, the Company is entitled to recover VE territory covered losses through periodic adjustments to the class A common stock conversion rates applicable to the UK&I and Europe preferred stock. The recovery has the same economic effect on earnings per share as repurchasing the Company’s class A common stock, because it reduces the UK&I and Europe preferred stock conversion rates and consequently, reduces the as-converted class A common stock share count.
The following table presents the reduction in as-converted UK&I and Europe preferred stock after the Company recovered VE territory covered losses through conversion rate adjustments in the three months ended December 31, 2020. There were no conversion rate adjustments in the three months ended December 31, 2019.
Three Months Ended
December 31, 2020
UK&IEurope
(in millions, except per share data)
Reduction in equivalent number of as-converted shares of class A common stock 
(1)
 
(1)
Effective price per share(2)
$209.89 $209.89 
Recovery through conversion rate adjustment
$9 $6 
(1)The reduction in equivalent number of shares of class A common stock was less than one million shares.
(2)Effective price per share for the quarter is calculated using the volume-weighted average price of the Company’s class A common stock over a pricing period in accordance with the Company’s current certificates of designations for its series B and C convertible participating preferred stock. Effective price per share is calculated using the weighted-average effective prices of the respective adjustments made during the year.
Common stock repurchases. The following table presents share repurchases in the open market for the following periods:
Three Months Ended
December 31,
20202019
(in millions, except per share data)
Shares repurchased in the open market(1)
9 13 
Average repurchase price per share(2)
$201.73 $179.27 
Total cost(2)
$1,796 $2,370 
(1)Shares repurchased in the open market reflect repurchases that settled during the three months ended December 31, 2020 and 2019. All shares repurchased in the open market have been retired and constitute authorized but unissued shares.
(2)Figures in the table may not recalculate exactly due to rounding. Average repurchase price per share and total cost is calculated based on unrounded numbers.
In January 2020, the Company’s board of directors authorized a $9.5 billion share repurchase program (the “January 2020 Program”) and in January 2021, authorized an additional $8.0 billion share purchase program. These authorizations have no expiration date. As of December 31, 2020, the Company’s January 2020 Program had remaining authorized funds of $3.7 billion. All share repurchase programs authorized prior to January 2020 have been completed.
Dividends. On January 26, 2021, the Company’s board of directors declared a quarterly cash dividend of $0.32 per share of class A common stock (determined in the case of class B and C common stock and series A, UK&I and Europe preferred stock on an as-converted basis), which will be paid on March 1, 2021, to all holders of record as of February 12, 2021. During the three months ended December 31, 2020 and 2019, the Company declared and paid dividends of $703 million and $671 million, respectively.